Table of contents

Original articles

• Participation of natural killer cells in the pathogenesis of bile duct lesions in biliary atresia (16 November, 2012)

  Atsushi Okamura, Kenichi Harada, Masaki Nio, Yasuni Nakanuma
• Is CDX2 immunostaining useful for delineating anorectal from penile/vulvar squamous cancer in the setting of squamous cell carcinoma with clinically unknown primary site presenting with histologically confirmed inguinal lymph node metastasis? (26 October, 2012)

  Sven Gunia, Stefan Koch, Matthias May
• Her2 amplification distinguishes a subset of non-muscle-invasive bladder cancers with a high risk of progression (19 October, 2012)

  Paul Chih-Hsueh Chen, Hui-Jung Yu, Yen-Hwa Chang, Chin-Chen Pan
• Prostate needle biopsy processing: a survey of laboratory practice across Europe (30 October, 2012)

  Murali Varma, Daniel M Berney, Ferran Algaba, Philippe Camparo, Eva Compérat, David F R Griffiths, Glen Kristiansen, Antonio Lopez-Beltran, Rodolfo Montironi, Lars Egevad
• Will PAXgene substitute formalin? A morphological and molecular comparative study using a new fixative system (3 November, 2012)

  Benedetta Belloni, Chiara Lambertini, Paolo Nuciforo, Jay Phillips, Eric Bruening, Stephane Wong, Reinhard Dummer
• Signet-ring cell carcinoma in gastric biopsies: expecting the unexpected (4 December, 2012)

  Christopher P Golembeski, Robert Maximilian Genta
• Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation (25 December, 2012)

  Ching-Hung Lin, Jacqueline M Liu, Yen-Shen Lu, Chieh Lan, Wei-Chung Lee, Kuan-Ting Kuo, Chung-Chieh Wang, Dwan-Ying Chang, Chiun-Sheng Huang, Ann-Lii Cheng
• CVID patients with autoimmunity have elevated T cell expression of granzyme B and HLA-DR and reduced levels of Treg cells (21 November, 2012)

  Clive R D Carter, Ganesha Aravind, Natuley L Smalle, June Y Cole, Sinisa Savic, Philip M D Wood